Madrigal Pharmaceuticals, Inc. Share Price: MDGL (Madrigal Pharmaceuticals, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Madrigal Pharmaceuticals, Inc. share price today?

Accepted Answer

Madrigal Pharmaceuticals, Inc. (MDGL) share price today is {{live_price}}.

Question 2

Can Indians buy Madrigal Pharmaceuticals, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Madrigal Pharmaceuticals, Inc. (MDGL) from India.

With INDmoney, you can buy Madrigal Pharmaceuticals, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Madrigal Pharmaceuticals, Inc. at zero transaction cost.

Question 3

How can I buy Madrigal Pharmaceuticals, Inc. shares from India?

Accepted Answer

It is very easy to buy Madrigal Pharmaceuticals, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Madrigal Pharmaceuticals, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Madrigal Pharmaceuticals, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Madrigal Pharmaceuticals, Inc. stocks?

Accepted Answer

To start investing in Madrigal Pharmaceuticals, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Madrigal Pharmaceuticals, Inc.

Accepted Answer

Today’s highest price of Madrigal Pharmaceuticals, Inc. (MDGL) is {{1_rba_end}}.

Today’s lowest price of Madrigal Pharmaceuticals, Inc. (MDGL) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Madrigal Pharmaceuticals, Inc.

Accepted Answer

Today's market capitalisation of Madrigal Pharmaceuticals, Inc. MDGL is 4.5B

Question 8

What is the 52 Week High and Low Range of Madrigal Pharmaceuticals, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Madrigal Pharmaceuticals, Inc. is down from its 52 Week High?

Accepted Answer

Madrigal Pharmaceuticals, Inc. (MDGL) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Madrigal Pharmaceuticals, Inc. is up from its 52 Week low?

Accepted Answer

Madrigal Pharmaceuticals, Inc. (MDGL) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Madrigal Pharmaceuticals, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Madrigal Pharmaceuticals, Inc.

Accepted Answer

Mr. William J. Sibold is the current Chief Executive Officer (CEO) of Madrigal Pharmaceuticals, Inc..

Period	Madrigal Pharmaceuticals, Inc.
3 Months	-26.11%
6 Months	-13.6%
1 Year	53.43%
3 Years	165.91%

Market Capitalization	4.5B
Book Value	$39.5
Earnings Per Share (EPS)	-25.55
PEG Ratio	0.0
Wall Street Target Price	362.53

Profit Margin	0.0%
Operating Margin TTM	-1110.38%

Return On Assets TTM	-47.27%
Return On Equity TTM	-106.27%

Revenue TTM	14.6M
Revenue Per Share TTM	0.74
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-529.6M
Diluted Eps TTM	-25.55
Quarterly Earnings Growth YOY	0.0

Madrigal Pharmaceuticals, Inc. (MDGL)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Madrigal Pharmaceuticals, Inc. Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-27.76
EPS Estimate Next Year	-18.42
EPS Estimate Current Quarter	-7.52
EPS Estimate Next Quarter	-7.05

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Madrigal Pharmaceuticals, Inc.	-12.69%	-13.6%	53.43%	165.91%	148.82%
Regeneron Pharmaceuticals, Inc.	-12.99%	6.13%	19.74%	81.09%	249.37%
Novo Nordisk A/s	-10.72%	-7.6%	27.93%	139.42%	357.36%
Alnylam Pharmaceuticals, Inc.	5.86%	70.96%	58.49%	30.96%	253.38%
Vertex Pharmaceuticals Incorporated	-3.35%	12.64%	28.18%	154.45%	168.54%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Madrigal Pharmaceuticals, Inc.	NA	NA	0.0	-27.76	-1.06	-0.47	NA	39.5
Regeneron Pharmaceuticals, Inc.	26.81	26.37	1.36	45.03	0.17	0.08	NA	261.41
Novo Nordisk A/s	38.76	38.76	1.75	3.39	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.49	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.54	0.32	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Madrigal Pharmaceuticals, Inc.	Buy	$4.5B	148.82%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$111.6B	249.37%	26.81	32.04%
Novo Nordisk A/s	Buy	$512.4B	357.36%	38.76	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$34.2B	253.38%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$115.8B	168.54%	32.84	-4.74%

Organization	Madrigal Pharmaceuticals, Inc.
Employees	376
CEO	Mr. William J. Sibold
Industry	Health Technology